0002127553-26-000001.txt : 20260427 0002127553-26-000001.hdr.sgml : 20260427 20260427171650 ACCESSION NUMBER: 0002127553-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260427 DATE AS OF CHANGE: 20260427 EFFECTIVENESS DATE: 20260427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NK-One Therapeutics, Inc. CENTRAL INDEX KEY: 0002127553 ORGANIZATION NAME: EIN: 413327449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-581982 FILM NUMBER: 26902129 BUSINESS ADDRESS: STREET 1: 526 PARK RIDGE DRIVE CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 610-733-0446 MAIL ADDRESS: STREET 1: 526 PARK RIDGE DRIVE CITY: WAYNE STATE: PA ZIP: 19087 D 1 primary_doc.xml X0708 D LIVE 0002127553 NK-One Therapeutics, Inc. 526 PARK RIDGE DRIVE WAYNE PA PENNSYLVANIA 19087 610-733-0446 DELAWARE NK-One Therapeutics, LLC None Corporation true 2026 Michael Shine 526 Park Ridge Drive Wayne PA PENNSYLVANIA 19087 Executive Officer Director Chief Executive Officer and President Marco Pappagallo 526 Park Ridge Drive Wayne PA PENNSYLVANIA 19087 Executive Officer Director Secretary Biotechnology Decline to Disclose 06b false 2026-03-04 false true false 0 310000 290000 20000 false 7 0 0 0 false NK-One Therapeutics, Inc. /s/Michael Shine Michael Shine Chief Executive Officer of Issuer 2026-04-27